August 9, 2011 — Acist Medical Systems Inc., a Bracco Group company and provider of advanced contrast injection system technology for cardiovascular angiography, announced that its’ Contrast Delivery System has been used to help diagnose and treat 10 million patients.

August 8, 2011 – Edwards Lifesciences announced the global launch of the Carpentier-Edwards Physio Tricuspid Annuloplasty Ring for the treatment of tricuspid valve insufficiency. The company received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE mark for European sales of the device.

August 8, 2011, — Cambridge Heart announced that the Freeport, Maine Fire Department has applied for a federal grant to establish firefighter screenings for sudden cardiac arrest (SCA) risk using the company’s Microvolt T-Wave Alternans (MTWA) non-invasive diagnostic test.

August 5, 2011 — Heart failure circulatory support system maker Thoratec Corp. announced it acquired the medical business of ventricular assist device (VAD) maker Levitronix Medical. The company developed a pediatric VAD, which is currently pending U.S. Food and Drug Administration (FDA) clearance. Levitronix was purchased in a cash payment of $110 million, as well as potential future cash earnout payments of up to $40 million.

August 5, 2011 — Vessix Vascular Inc. (formerly known as Minnow Medical Inc.), developer of novel percutaneous radiofrequency (RF) balloon catheter technology for peripheral leg vessels, announced it has completed a $23 million Series B preferred stock financing.

August 5, 2011 – Children’s Memorial Hospital in Chicago will install Merge Healthcare’s iConnect software suite (vendor-neutral archive [VNA], access and share) at its 270-bed facility.

August 3, 2011 — AmbiCom Holdings Inc., developer of wireless products for medical equipment suppliers, announced that it has signed an agreement with a major medical device manufacturer to jointly develop a Wi-Fi card application for its cardiac defibrillator product.